A PYMNTS Company

AbbVie, Abbott Sued by Perrigo Over AndroGel Generic Delay

 |  May 4, 2020

Perrigo sued AbbVie in Philadelphia federal court Monday, claiming its scheme to delay competition for the blockbuster testosterone booster AndroGel kept the Israeli drugmaker’s generic version off pharmacy shelves, reported Bloomberg Law. 

The antitrust lawsuit also targets AbbVie’s former parent Abbott Laboratories, AbbVie subsidiary Unimed Pharmaceuticals, and Besins Healthcare, a Belgian company that partnered with Unimed to develop AndroGel. It was filed in the US District Court for the Eastern District of Pennsylvania.

Full Content: Bloomberg

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.